| Product Code: ETC7743684 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 Japan Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.8 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.9 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of non-Hodgkin lymphoma cases in Japan |
4.2.2 Growing awareness and early diagnosis initiatives |
4.2.3 Technological advancements in diagnostic tools and techniques |
4.3 Market Restraints |
4.3.1 High cost associated with diagnostic procedures |
4.3.2 Limited access to advanced diagnostic facilities in remote areas |
4.3.3 Stringent regulations and approvals for diagnostic products |
5 Japan Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Types |
6.1 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.1.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Genetic Test, 2021- 2031F |
6.1.8 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.1.9 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Cancer Stage |
6.2.1 Overview and Analysis |
6.2.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage 0, 2021- 2031F |
6.2.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Ii, 2021- 2031F |
6.2.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iii, 2021- 2031F |
6.2.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iv, 2021- 2031F |
6.3 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Tumor Type |
6.3.1 Overview and Analysis |
6.3.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Aggressive Lymphomas, 2021- 2031F |
6.3.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Indolent Lymphomas, 2021- 2031F |
6.4 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Instrument Based Products, 2021- 2031F |
6.4.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Platform Based Products, 2021- 2031F |
6.4.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Kits And Reagents, 2021- 2031F |
6.4.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Other Consumables, 2021- 2031F |
6.5 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021- 2031F |
6.5.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.5.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorimmunoassay, 2021- 2031F |
6.5.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.5.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemical, 2021- 2031F |
6.5.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Screening, 2021- 2031F |
6.6.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic And Predictive, 2021- 2031F |
6.6.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Prognostic, 2021- 2031F |
6.6.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Research, 2021- 2031F |
6.7 Japan Non-Hodgkin Lymphoma Diagnostics Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.7.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Japan Non-Hodgkin Lymphoma Diagnostics Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.8.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By , 2021- 2031F |
7 Japan Non-Hodgkin Lymphoma Diagnostics Market Import-Export Trade Statistics |
7.1 Japan Non-Hodgkin Lymphoma Diagnostics Market Export to Major Countries |
7.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Imports from Major Countries |
8 Japan Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
8.1 Average time taken for diagnosis |
8.2 Rate of adoption of advanced diagnostic technologies |
8.3 Number of research collaborations for improving diagnostic accuracy |
8.4 Patient survival rates post early diagnosis |
8.5 Percentage of healthcare providers trained in non-Hodgkin lymphoma diagnostics |
9 Japan Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
9.1 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.3 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.4 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.5 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Japan Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
10.1 Japan Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Japan Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here